Several recent developments in U.S. standard-essential patent litigation (SEP) provide insight into the evolving U.S. SEP landscape and how parties and courts shape parties’ obligations to negotiate licenses for SEPs on fair,...more
Hogan Lovells’ Standard Essential Patent (SEP) Update reports on recent news and case decisions from jurisdictions including China, France, Germany, Italy, Japan, the Netherlands, Spain, the United Kingdom and the United...more
8/8/2019
/ 5G Network ,
Anticompetitive Behavior ,
Antitrust Provisions ,
Blackberry ,
China ,
Federal Trade Commission (FTC) ,
FRAND ,
Huawei ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
IP License ,
Patents ,
Philips Electronics ,
Qualcomm ,
Standard Essential Patents ,
The Hague ,
Unfair or Deceptive Trade Practices
In a decision following a 10-day bench trial, Judge Lucy H. Koh ruled on May 21, 2019 in favor of plaintiff U.S. Federal Trade Commission (“FTC”) that defendant Qualcomm, Inc.’s (“Qualcomm’s”) licensing practices relating to...more
6/12/2019
/ Anticompetitive Behavior ,
Antitrust Provisions ,
Cell Phones ,
Corporate Counsel ,
Exclusive Licenses ,
Federal Trade Commission (FTC) ,
FRAND ,
FTC Act ,
Intellectual Property Protection ,
Internal Communications ,
IP License ,
Microchip Technology ,
Monopolization ,
Patent Royalties ,
Qualcomm ,
Sherman Act ,
Standard Essential Patents ,
Telecommunications
Hogan Lovells’ Standard Essential Patent (SEP) Update reports on recent news and case decisions from jurisdictions including China, France, Germany, Italy, Japan, the Netherlands, Spain, the United Kingdom and the United...more
5/20/2019
/ Automotive Industry ,
China ,
Connected Cars ,
France ,
FRAND ,
Germany ,
Huawei ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
IP License ,
Netherlands ,
Non-Practicing Entities ,
Patents ,
Standard Essential Patents ,
Telecommunications ,
UK
Hogan Lovells’ U.S. + German Patent Update reports on recent patent news and cases from Germany and the United States.
...more
4/16/2019
/ Amazon Marketplace ,
Federal Pilot Programs ,
Foreign Patent Applications ,
Germany ,
Intellectual Property Protection ,
IP License ,
Motion to Amend ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Product Recalls
Hogan Lovells’ Standard Essential Patent (SEP) Update reports on recent news and case decisions from jurisdictions including China, France, Germany, Italy, Japan, the Netherlands, Spain, the United Kingdom and the United...more
Hogan Lovells’ Standard Essential Patent (SEP) Update reports on recent news and case decisions from jurisdictions including China, Germany, Japan, the United Kingdom, and the United States.
...more
1/9/2019
/ 5G Network ,
Antitrust Litigation ,
China ,
Federal Trade Commission (FTC) ,
FRAND ,
Germany ,
Huawei ,
Intellectual Property Protection ,
IP License ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Qualcomm ,
Royalties ,
Samsung ,
Standard Essential Patents ,
Telecommunications ,
UK
The U.S. and Germany are two of the most important fora in the world for patent litigation. The U.S. has long been one of the largest markets for patent litigation, and Germany has constantly attracted more than 50% of all...more
10/24/2018
/ FRAND ,
Germany ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
IP License ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Post-Grant Review ,
Sovereign Immunity ,
Tribal Governments
16 April 2018 – Huawei’s jurisdictional challenge to Conversant Wireless’ patent infringement and FRAND determination proceedings has been dismissed by the High Court of England and Wales. ...more
6/28/2018
/ China ,
FRAND ,
Huawei ,
Injunctions ,
Intellectual Property Protection ,
IP License ,
Jurisdiction ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Qualcomm ,
Samsung ,
Standard Essential Patents ,
Telecommunications ,
Wireless Industry
On February 23, 2018, in a much-anticipated decision, the PTAB ruled that tribal sovereign immunity could not be used to shield certain Allergan Inc. (“Allergan”) patents from review in a number of IPRs. Allergan had assigned...more
2/28/2018
/ Allergan Inc ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
IP License ,
Native American Issues ,
Patent Invalidity ,
Patent Ownership ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Post-Grant Review ,
Sovereign Immunity ,
Tribal Governments